|
Quotes & Info
|
| ILMN > SEC Filings for ILMN > Form 8-K on 21-Nov-2012 | All Recent SEC Filings |
21-Nov-2012
Other Events, Financial Statements and Exhibits
On November 20, 2012, Illumina, Inc. sent a letter to the Board of Directors of Complete Genomics, Inc., regarding Illumina's proposal to purchase all of the outstanding common stock of Complete Genomics. A copy of the letter is attached hereto as Exhibit 99.1.
(d) Exhibits.
99.1 Letter dated November 20, 2012, from Illumina, Inc. to the Board of Directors of Complete Genomics, Inc.
|
|